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ABSTRACT
Various studies have shown neuropotency of bone marrow-derived human mesenchymal stem cells (hMSC)
based on the appearance of cells with neural phenotype before or after neural induction protocols. However,
to date, it is unclear which mechanisms account for this observation. We hypothesized that neural phenotypes
observed in hMSC cultures can be because of both intrinsic cell plasticity and contamination by cells of neural
origin. Therefore, we characterized 38 clones from hMSC cultures by assessing their adipogenic/osteogenic
potential with specific mesenchymal differentiation protocols, and their molecular neural phenotype by RT-
PCR analysis before and after exposure to a defined neural stem cell (NSC) medium for 8 days (neural protocol).
We found 33 clones with mesenchymal potential and 15 of them also showed a neural phenotype. As neural phe-
notypes were maintained during the neural protocol, this suggested neural cell plasticity in 39% of all clones
through pluripotency. Importantly, we were able to induce neural phenotypes in 11 of mesenchymal clones
applying the neural protocol, demonstrating neural cell plasticity in 29% of all clones through the mechanism
of transdifferentiation. Finally, 2 of 5 nonmesenchymal clones (5% of all clones) displayed a neural phenotype
indicating neural cell contamination of hMSC cultures. In conclusion, we found 2 different ways of neuropotency
of hMSC cultures: cell plasticity and cell contamination.
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Bone marrow contains hematopoietic stem cells
(HSC) andmesenchymal stem cells (MSC), also termed
multipotent stromal cells, which can be separated in vi-
tro by the property of MSC to adhere to plastic. They
can be identified using standard MSC markers, as al-
pha-smooth muscle actin (ASMA) and surface marker
CD105, and the absence of expression of the HSC
markersCD45 andCD34 for theirmolecular character-
ization [1,2]. However, the ‘‘gold standard’’ to label
these cells as MSC is the probe of their ability to differ-
entiate into adipocytes, osteocytes, and chondrocytes
[3,4]. On the other hand, various in vitro studies showed
neuropotency of human MSC (hMSC) based on their
expression of specific neural protein after in vitro stimu-
lation with neural differentiation media [5,6]. In agree-546ment with other definitions, ‘‘transdifferentiation’’
represents the activation of a new differentiation pro-
gram.Therefore,whenresearchers show the appearance
of neural phenotypes in hMSC cultures after applying
neural induction media, they argue that cells are trans-
differentiating toward neural lineage [7]. Recently, it
has been shown that undifferentiated hMSC cultures
isolated by plastic adhesion expressed low levels of neu-
ral-specific markers before any differentiation [8]. To
date, it is unclear why some undifferentiated hMSC cul-
ture-derived cells have neural phenotype. We suggest
that thismight be because of pluripotency of hMSC cul-
ture-derived cells and also the presence of contaminated
neural cells in the cultures.
To prove our hypothesis, we established clones
from hMSC cultures and characterized them assessing
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gene expression patterns before and after exposure to
the neural protocol. Data analysis allowed us to define
the clones as mesenchymal versus nonmesenchymal
and place them in a hierarchy relative to their molecular
neural phenotype considering that neuroD1 expression
revealed neural fate [9]; nestin expression, neural stem
cell (NSC)phenotype [10];mediumchainneurofilament
(NF-M) expression, neuronal phenotype [11] and,
GFAP and GalC expression, glial phenotypes [12,13].
Our clonal study demonstrates that the neuropo-
tency of hMSC cultures depends on both mesenchy-
mal and nonmesenchymal subpopulations of cells,
including those of neural origin, which are present in
bone marrow-derived cultures. Additionally, our neu-
ral protocol may serve to efficiently obtain neural-like
cells from hMSC cultures.
MATERIAL AND METHODS
Isolation and Expansion of hMSC Cultures
Leftover material was obtained from 4 heparinized
aspirates of bone marrow from normal individuals
undergoing bone marrow harvests for allogeneic trans-
plantation, as part of a protocol approved by the Ethical
Committee of the Hematology Department of Clinica
Alemana (Santiago, Chile). Samples were diluted in 1/
5 (v/v) phosphate-buffered saline (PBS) and centrifuged
at 400  g for 7 minutes. Total cells were seeded at a
density of 1  106 nucleated cells/cm2 in a-10 medium
composed by a-minimal essential medium (a-MEM,
Gibco,Grand Island,NY) supplementedwith10%fetal
bovine serum (FBS) (v/v), 0.8 mg/L gentamicine (Bio-
sano laboratory, Santiago, Chile). Cultures were incu-
bated in a humidified atmosphere at 37C in 5% CO2.
After 24 hours, nonadherent cells were removed by
replacing culture medium. When foci of fibroblastic-
like cells were confluent, cells were detached with
0.25% (p/v) trypsin, 2.65mMEDTA (Gibco), and sub-
cultured at 7 103 cells/cm2 for further expansion. Iso-
lated cells were characterized by real-time RT-PCR for
CD34, CD105, and ASMA, together with the evalua-
tion of their capacity to differentiate in vitro into adipo-
cytes, chondrocytes, and osteocytes.
Isolation and Expansion of hMSC Culture-Derived
Clones
Clones were obtained from hMSC cultures by lim-
iting dilution. Briefly, 100 cells/well were seeded in the
first column of a 96-well plate, and immediately serial
1:2 dilutions were performed to reach 1 cell/well. To
ensure single-cell clones, wells were examined daily
under a phase-contrast microscope, and those contain-
ingmore than 1 cell were excluded from the study. Sin-
gle cells cultured in fresh medium were not able to
proliferate. Single cells only grew when cultured with
a mixed medium composed of 50% fresh mediumand 50% conditioned medium collected from subcon-
fluent hMSC cultures after 48 hours, centrifuged, and
filtered through a 0.2 mm filter (Fisher Scientific Inter-
national Inc., Pittsburgh, PA) to eliminate cellular
components. Clones were expanded and further char-
acterized according to their mesenchymal and neural
phenotypes.
Mesenchymal Differentiation Protocols
For adipogenic and osteogenic lineages, cells were
seeded at a density of 2.5 104 cells/cm2 and later stim-
ulated with adipogenic (a-10 medium supplemented
with 100 mg/mL isomethylbutylxanthine [Calbiochem,
La Jolla, CA], 1 mM dexamethasone, 0.2 U/mL insulin
[Humalog], and 100 mMindomethacin [Sigma-Aldrich,
St. Louis, MO], or osteogenic (a-MEM 1 10% FBS
with 0.1 mM dexamethasone, 50 mg/mL ascorbate-2-
phosphate, and 10 mM b-glycerophosphate; Sigma-
Aldrich) differentiation media during 10 and 21 days,
respectively. Nonstimulated cultures were used as con-
trol and maintained in a-10 medium. Media were
replaced twice a week. To assess adipogenic and osteo-
genic differentiation, intracellular lipid droplets were
revealed by staining with Oil Red O (Merck, West
Point, PA) and matrix mineralization by staining with
Alizarin Red (Sigma-Aldrich), respectively [1].
For chondrogenic lineage, cells were cultured at
a density of 5  103 cells/mL in 10 mL of a-10 medium
to achieve the adequate tridimensional conditions for
micromass formation. After 2 hours the a-10 medium
was replaced with the chondrogenic differentiation
medium modified from that used by Pittenger et al.
[3]. After 7 days, the proteoglycans that compose the
extracellular matrix of the micromass were revealed
by staining with Safranin O (Merck).
Neural Protocol
Cells were seeded in a-10medium at a density of 4-
6  103 cells/cm2. After 24 hours, the medium was
replaced with NSCmedium similar to that used in hu-
man NSC cultures [14], containing DMEM/F12 (1:1)
(Gibco), 1% bovine serum albumin (BSA, Merck), 6
g/LD(1)-glucose (Merck), 0.8 mg/L gentamicin, sup-
plemented with N2 and B27 supplements (Gibco),
human epidermic growth factor (EGF), and human ba-
sic fibroblast growth factor (bFGF), both at 10 ng/mL
(R&D Systems, Minnespolis, MN), in which the cells
were cultured until the end of the experiment. Neural
phenotype was evaluated according to the pattern of
expression of neural genes, before (0 days) and after
(8 days) exposure to NSC medium.
Isolation and Characterization of Rat NSC (rNSC)
from Olfactory Bulbs
Two olfactory bulbs were isolated from each post-
natal (P0-P4) rat. Disaggregated cells were plated in
suspension at cell density of 6  105 cells/mL in
548 R. Somoza et al.7-10 mL of neural medium (DMEM/F12 (1:1), 1%
bovine serum albumin, 6 g/L D(1)-glucose, 0.8 mg/
L gentamicine) supplemented with 10% FBS. After
24 hours, cell suspension was centrifuged at 600  g
for 15 minutes and the neural growth medium was
replaced with NSC medium, the same medium used
for neural protocol. Cells growing in suspension
formed cellular aggregates named neurospheres, and
after 2-3 days were functionally characterized by their
capacity to generate neurons and glial cells.
RT-PCR Analysis
Total RNA was isolated from cells using TRI-
ZOL reagent (Invitrogen, Carlsbad, CA) according
to the instruction of the manufacturer. RNA con-
centration was determined spectrophotometrically
followed by treatment with RNase-free DNase (Invi-
trogen). Then, 1 mg of total RNA was used for reverse
transcription of mRNA molecules to DNA copies.
Real-timePCRwas performed in a capillary containing
100 ng of cDNA, PCR LightCycler-DNA Master
SYBR Green reaction mix (Roche, Indianapolis, IN),
3-4mMMgCl2, and 0.5mMof each specific primer, us-
ing a LightCycler thermocycler (Roche). Total RNA
from the U87 human glioblastoma cell line [15] was
used as positive control for neuroD1, nestin, NF-M,
and GFAP genes. To ensure that amplicons were
derived frommRNA and not genomicDNA amplifica-
tion, negative controls without reverse transcriptase
(2RT) were perform. Negative PCR results were vali-
dated by amplification of the housekeeping gene
GAPDH. To determinate the PCR sensitivity for
each neural gene, serial dilutions of known amplicon
concentration were reamplified, and the minimum
quantity of cDNA (detection limit) that could be
detected was calculated (Figure 1).
RESULTS
Characterization of hMSC Cultures
hMSC from 4 bone marrow samples were selected
by plastic adhesion, and cultures were characterized
after passage 1 (Figure 2).Cells proliferated ina-10me-
dium and had a doubling time that ranged between 38
and 77 hours (data not shown). Protein and/or gene ex-
pression ofmarkers described to be expressed onhMSC
was detected in the cultures (ASMA and CD105;
Figure 2B and F). hMSC culture-derived cells differen-
tiated under specific induction media into adipocytes,
osteocytes, and chondrocytes (Figure 2C-E), which
demonstrated the functional properties of hMSC [1-4].
In addition, hMSC cultures expressed neural-lineage
markers such as neuroD1, nestin, NF-M, GFAP, and
GalC, but did not express hematopoietic markers
as CD34 in undifferentiated culture conditions
(Figure 2F).Mesenchymal and Nonmesenchymal Phenotypes
of hMSC Culture-Derived Clones
hMSC culture-derived clones were generated from
a total of 72 single cells obtained by limiting dilution
method. Clonal efficiency ranged between 15% and
70%, obtaining 38 total clones that duplicated 18 times
before characterization (Table 1). All 38 clones were
induced by specific media (see Material and Methods)
to either differentiate into adipogenic and osteogenic
lineages to evaluate their mesenchymal potential. We
found that the vast majority of clones differentiated
into adipocytes and/or osteocytes. As previous clonal
study demonstrated that adipogenic and osteogenic
potentials are linked to the chondrogenic phenotype,
clones that differentiated into both mesenchymal line-
ages were considered as MSC [4,16]. Thus, isolated
clones represented phenotypes of MSC, adipogenic
precursors (AdP), osteogenic precursors (OsP), and
also nonmesenchymal phenotype (Figure 3). In sum-
mary, we obtained 33 mesenchymal clones (MSC,
AdP, andOsP) and5nonmesenchymal clones (Table 2).
Neural Phenotypes Observed in Undifferentiated
hMSC Culture-Derived Clones
To investigate the neuropotency of hMSC culture-
derived clones, we first analyzed the expression of neu-
ral genes in undifferentiated culture conditions. The
majority of mesenchymal clones expressed the neural
fate marker neuroD1. Additional expression of neuro-
nal marker (NF-M) or glial markers (GFAP and/or
GalC) was observed, indicating a neuronal or glial phe-
notype. We did not obtain any clone that had exclu-
sively an oligodendrocytic phenotype. So, the
expression of oligodendroglial marker GalC was al-
ways linked to GFAP expression. We also found 3
clones that coexpressed neuronal plus glial markers
(neuroglial phenotype, Table 2). In addition, we clas-
sified as pseudoneural phenotype 4 clones that ex-
pressed neural genes except the transcription factor
neuroD1. In summary, we found 15 mesenchymal
clones that expressed neural genes in undifferentiated
culture conditions (Table 2). On the other hand,
only 2 of 5 nonmesenchymal clones showed a neural
phenotype (Table 2). These 2 clones might be consid-
ered as a subpopulation of neural cells that are contam-
inated by the hMSC cultures. We also found 12
mesenchymal clones that did not express any of the
neural genes analyzed (nonneural phenotype, Table 2).
Neural Phenotypes Observed in hMSC Culture-
Derived Clones after Applying the Neural Protocol
To demonstrate the neuropotency of the undiffer-
entiated clones with neural phenotype (15 mesenchy-
mal and 2 nonmesenchymal; Table 2) we exposed
them to the neural protocol. We observed changes in
the morphology and also in the pattern of neural gene
Neuropotency of Human Mesenchymal Stem Cell Cultures 549Figure 1. Real-time PCR analysis for mRNA detection. (A) Melting temperature (Tm) for amplicons was calculated from peaks obtained from –
d[F]/dT versus T plots (F5 SYBRGreen fluorescence; T5 C) using a LightCycler thermocycler (n5 3-5 reactions). Theorical amplicon size
was verified by DNA-electrophoretic analysis (showed on the left side of each melting curve). Graphics at the botton of part A show represen-
tatives fluorescent-amplification profiles and a standard curve for GAPDH used to determinate the detection limit for PCR product. (B) Se-
quences of primers used and characteristic of the amplicons. n.d.: not determinatedexpression in most clones (Figure 4). In some mesen-
chymal clones, cells began to form neurosphere-like
structures and detached from the dish after exposure
to the neural protocol (clone B10), whereas in others,
these cellular aggregates kept attached until the end
of the experiment (clone A08). Interestingly, these
clones that showed an NSC-like morphology exclu-
sively expressed neuroD1 gene after applying the neu-
ral protocol (Figure 4A). We found mesenchymal
clones that maintained their patterns of neural gene ex-
pression, and other that upregulated or downregulated
neural genes in response to the neural protocol
(Figure 5A-C). On the other hand, 11 of 12 mesenchy-
mal clones (.90%)withnonneural phenotype (Table 2)upregulated expression of neural genes after apply-
ing the neural protocol. These clones responded to
the neural protocol changing their neural gene expres-
sion pattern in a differentmanner (Figure 5B).With re-
gard to the nonmesenchymal clones with a neural
phenotype, clone C02 showed a mature neural-like
morphology together with a multineural gene expres-
sion pattern, after applying the neural protocol
(Figure 4A).
DISCUSSION
Our clonal analysis showed that the mesenchymal
potential is maintained in 87% of isolated hMSC
550 R. Somoza et al.Figure 2. Cellular and molecular characterization of hMSC cultures. (A) Cells showed a fibroblastic-like morphology and (B) immunolabeled
using FITC-conjugated anti-ASMAmonoclonal antibody. (C) hMSC culture-derived cells differentiate into adipocytes, (D) osteocytes, and (E)
chondrocytes. (F) Gene expression profile of hMSC cultures using RT-PCR assay.1, detected;2, nondetected;1/2, detected in some samples.
Scale bars: 100 mm.culture-derived clones (33 of 38, Table 2). The distinct
mesenchymal phenotypes that we found (MSC, AdP,
and OsP; Figure 3) confirmed that hMSC cultures are
composed of heterogeneous populations of mesenchy-
mal progenitors with different commitment, as Mura-
glia et al. [16] have demonstrated before. They also
demonstrated that the mesenchymal potentials in
hMSC clones were maintained for up to 22 cell dou-
blings. Considering this evidence, we decided just to
expand clones to no more than 18 cell doublings, as-
suming that the mesenchymal potential of our clones
did not change during the expansion process. Thus,
for each clone we obtained a limited number of cells
(approximately 2 105 cells) that were used for mesen-
chymal and neural phenotyping. Because of the limited
number of cells, neither immunolabeling nor electro-
physiologic studies could be done. Instead, we charac-
terized the neural phenotype based on the analysis of
neural markers by RT-PCR.
According to other investigators, in the absence of
functional data the analysis of the pattern of neural
gene expression is more appropriate than immunolab-
eling to draw conclusions about the event of neural cell
plasticity of hMSC [17,18]. This has been elucidated in
an experiment, where apparent increases in expression
of neuronal proteins, such as neuronal NSE (after ap-
plying neural induction media), also occurred when
protein synthesis was inhibited [18]. Furthermore, to
evaluate the event of neural cell plasticity of hMSC,
it is important to emphasize that transdifferentiation
involves genetic reprogramming, requiring the induc-
tion of some genes and the inhibition of others (withturning off and turning on of some genes) [19]. There-
fore, if hMSC culture-derived clones could acquire
a commitment toward a neural fate, an incipient cellu-
lar process might be detected at a transcriptional level.
However, we did not expect to obtain mature neural
cells as functional neurons using our protocol because
(NSC medium is similar to other media used to ex-
pand undifferentiated neural cells, and 8 days is a short
time frame for completing a neuronal differentiation
process).
Finally, it has been described that neural-like cells
derived from hMSC cultures can be an artefact because
of the exposure to chemical stress [17,18]. Although all
soluble factors present in theNSCmediumwerenoncy-
totoxic (we also used this medium to expand rNSC ob-
tained from olfactory bulbs; seeMaterial andMethods),
there was a change in morphology of clones A08 and
C02 but not in their neural gene expression pattern.
Therefore, the morphologic change may be given by
the exposure to a serum-free medium (Figure 4A).
Thus, the conclusions to characterize thedistinct neural
phenotypes of clones were based on their neural gene
expression pattern rather than on their morphology.
Specifically, the neuronal phenotype was defined by
the expression of NF-M, the glial phenotype by the
expression of GalC and/or GFAP, and neuroglial phe-
notype by coexpression of NF-M and the glial markers
GFAPandGalC (seeTable2 andFigure 5A) todescribe
clones that had both neuronal and glial phenotype.
NeuroD1 must be expressed in all neural cells, as it
has been demonstrated that this transcription factor is
necessary for development and maintenance of neural
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ther express neuroD1 nor other neural marker were
labeled as nonneural phenotypes, and those positive
for any neural marker except neuroD1 as pseudoneural
phenotypes (Table 2). On the other hand, it has been
demonstrated that neuroD1 promotes the generation
of progenitors localized in adult brain regions where
there are immature and multipotent NSC [9], and the
Table 1. Property Differences between hMSC Culture-Derived Clones
hMSC Culture*
Number of
Passage
Number of Wells
with a Single Cell†
Number of
Clones
Clonal
Efficiency (%)
Expansion
Time‡ (Days)
A 4 15 10 67 30-35
B 1 27 19 70 25-29
C 3 20 3 15 38
D 1 10 6 60 22-30
*From 4 different donors (A-D).
†Obtained by limiting dilution method.
‡Up to 2  105 cells.
Figure 3. Mesenchymal potential of four representative hMSC culture-derived clones. Adipogenesis assessed by accumulation of lipid vacuoles
(Oil Red O), osteogenesis indicated by extracellular calcium salts deposition (Alizarin Red). AdP: adipogenic precursors; OsP: osteogenic pre-
cursors. Scale bars: 100 mm.
552 R. Somoza et al.absence of neuroD1expression in knockoutmice affects
to neurogenesis in the hippocampus [21]. Interestingly,
some neuroD1-positive mesenchymal clones had the
capacity to form cellular aggregates similar to neuro-
spheres seen in rNSC cultures (Figure 4), were able to
proliferate (data not shown), or to express neural genes
of neurons and glial cells (Figure 5C), during the expo-
sure to the NSC medium. According to other hMSC
Table 2. Mesenchymal* and Neural† Phenotypes of hMSC Culture-Derived Clones‡
MSC AdP OsP Nonmesenchymal
Nonneural A10, A06, D05 B27, A02, D08, B14, A07, B05, B13, B15 B07 D02, D07
NSC-like A08 B03, B04, A04, B01, B06, B11 _ _
Neuronal B18, D03 A03, B19, B16 _ _
Neuroglial A09 _ _ C02, D06
Glial A05, B08 B02, B09 B10 _
Pseudoneural A01 C01, C03 _ B17
*Thirty-eight clones analyzed by in vitro differentiation into adipocytes and osteocytes.
†Thirty-eight clones analyzed by RT-PCR in undifferentiated culture conditions.
‡Clone labels composed by respective donor letter (A-D) and clone number (01-19), for example, A08, B15, etc.
Figure 4. Phenotypical changes in hMSC culture-derived clones after applying the neural protocol. (A) Photomicrographs showed no differences
in the adherence to plastic and cell morphology between representative mesenchymal (B10 and A08) and nonmesenchymal (C02) clones before
exposure to the neural protocol (d0), although there were differences in the neural gene expression pattern. Floating and adherent neurosphere-
like structures and mature neural-like cells appear after applying the neural protocol (d8). (B) Typical morphology of rNSC culture-derived cells
in different states of differentiation. Scale bars: 50 mm.
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chymal clones canbecommitted towardanNSCpheno-
type. Therefore, in our study, all clones that exclusively
expressed the neural gene neuroD1 were classified as an
NSC-like phenotype. Although nestin protein is usually
expressed in NSC from neural tissue [23] and has been
used in various MSC studies as indicative of an NSC-
like phenotype [5,22], we did not find expression of
nestin in our clones (discussed later). Thus, our data
indicate that the expression of the neuroD1 gene but
not the nestin gene is necessary to induce an NSC-like
phenotype inclonesderived fromhMSCcultures.How-
ever, to confirm that these clones are NSC, it will be
necessary to graft them into the mammalian nervous
system and demonstrate their in vivo potential to differ-
entiate into the 3 neural lineages by detecting neuronal,
astrocytic, and oligodendrocytic cells.
The presence of clones with different grades of
neural commitment before applying the neural proto-
col (18% NSC-like, 13% neuronal, 8% neuroglial,
and 13% glial phenotypes; Table 2) could explain
why hMSC cultures expressed basal levels of all
markers of undifferentiated and mature neural cell
states in undifferentiated culture conditions
(Figure 2F). In addition, our data suggest that some
neural phenotypes were linked to a specific mesenchy-
mal phenotype: neuroglial phenotype was restricted to
AdP clones, and glial phenotype was related exclusively
to OsP clones (see Table 2).
Neural cell plasticity. In agreement with other
definitions, ‘‘transdifferentiation’’ is the mechanism
by which the cell acquires phenotypes distinct from
its original lineage [7]. In this way, 11 mesenchymal
clones with a nonneural phenotype (Table 2) showed
neuropotency upon the application of the neural proto-
col (Figure 5B). Therefore, we demonstrate neural cell
plasticity in 11 of 33 mesenchymal clones through
a transdifferentiation mechanism. On the other hand,
Figure 5. Mechanisms to explain neuropotency in hMSC culture-derived clones. (A) Distinct neural gene expression patterns found in clones
before and after applying the neural protocol are represented in this chart. (B,C) Mesenchymal clones showed neural cell plasticity given by
the mecanisms of transdifferentiation (B, 11 clones) and pluripotency (C, 15 clones). (D) The existence of 2 nonmesenchymal clones with neuro-
potency indicates neural cell contamination. Arrows represent the theoretical gene expression-routes of each clone. Beginning and end of arrows
are related to neural gene expression patterns before and after the application of the neural protocol, respectively; dotted rectangles indicate non-
differentiated clones; black and white arrows indicate clones maturing and dedifferentiating, respectively.
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type of undifferentiated hMSC cultures could indicate
a predisposition to differentiate into neural lineages
and therefore an intrinsic neuropotency. Furthermore,
it has been postulated that pluripotency showed in
some somatic stem cells is because of the high accessi-
bility of chromatin, allowing them to express many dif-
ferent lineage-specific genes [24]. Herein, we found 18
clones that have both mesenchymal and neural pheno-
types (Table 2). Fifteenof themalso have neural pheno-
types after applying the neural protocol (Figure 5C),
and therefore indicates that they had intrinsic neuropo-
tency because of their pluripotent properties. So, ‘‘plu-
ripotency’’ reveals another mechanism (different of
‘‘transdifferentiation’’) by which 15 of 33mesenchymal
clones have neural cell plasticity. In summary, the
clonal evidence of transdifferentiation and pluripo-
tency confirm and demonstrate in vitro the neural cell
plasticity of hMSC culture-derived cells with mesen-
chymal potential.
Neural cell contamination. It has been suggested
that bonemarrow is a reservoir of stemcells and progen-
itors fromdifferent tissues [25], not onlyHSCandMSC.
We found 5 nonmesenchymal clones in our study, and 2
of themhadneural phenotypebefore and after the appli-
cation of the neural protocol (Figure 5D). The other 3
nonmesenchymal clones did not express any neural
gene. Previously, other investigators did not find any
nonmesenchymal phenotype in their clonal study [16].
This discrepancy with our data could be explained by
thedifferent isolationmethodsused.AlthoughMuraglia
et al. [16] isolated clones directly from bone marrow
samples, we obtained our clones from hMSC cultures
after selecting thembyadherence toplastic. Primary hu-
manNSC can also adhere to the dish and adopt a fibro-
blastic-like morphology when cultured in medium
containing serum. Therefore, the culture conditions
used to isolate bone marrow-derived hMSC might also
serve to obtain neural progenitor cells that can be pres-
ent in thebonemarrow.The fundingof2nonmesenchy-
mal clones with neuropotency (Figure 5D) is in
agreement with a recent study that demonstrates the
presence of neural crest-derived stem cells in rodent
adult bone marrow [26]. The 18 cell doublings before
obtaining clones from a single cell, allowed us to charac-
terize themas progenitor cells.However,what could ex-
plain the survival and expansion of ‘‘contaminated’’
neural progenitors in our clonal study? The answer
could be found within the expansion medium we used
(50% fresh medium and 50% conditioned medium).
WedetectedBDNFprotein byELISA (data not shown)
in the hMSC culture-derived conditioned medium
used during the clonal expansion process. A previous
work demonstrated the positive effect of hMSC-condi-
tioned medium on the survival of neural cells because
of the presence of neurotrophic factors such as BDNF
and NGF [27]. Thus, BDNF present in our hMSCculture-derived conditioned medium could have al-
lowed the survival and expansion of the 2 nonmesenchy-
mal cloneswithneural phenotype foundbefore applying
theneural protocol (Table 2).On theother hand, a study
evaluated the effect of exogenous BDNF added to
hMSC cultures and found that this neurotrophic factor
induced the expressionofneuronal andglialmarkers and
downregulated nestin gene expression [28]. Therefore,
theBDNFof ourhMSC-conditionedmediumcould ex-
plain the absence of nestin in the clones. In addition, we
cannot exclude the fact that BDNF present during the
expansion process induced the expression of neural ge-
nes in the mesenchymal clones that showed neural phe-
notype in undifferentiated culture conditions (Table 2),
including the 15 pluripotent clones (Figure 5C).
Taken together, our results demonstrated that neu-
ral cell plasticity can be reached in 68% of all hMSC
culture-derived clones, either by transdifferentiation
or pluripotency mechanisms. In addition, we have evi-
dence of cell contamination with neural progenitors in
the hMSC cultures (40% of nonmesenchymal clones).
In addition, our results using hMSC culture-derived
clones obtained from adult human bone marrow sug-
gest that hMSC cultures are heterogeneous with re-
spect to the tissue-specific progenitors they contain,
not only those derived from mesenchymal lineages
but also fromneural lineages. Finally, our neural proto-
colwas able to induceneural phenotype in.90% (11of
12) of the mesenchymal clones that previously did not
show a neural phenotype. Thus, in the absence of
standarized neural induction media, our neural proto-
col is a good alternative to enrich hMSC cultures de-
rived from bone marrow with cells committed toward
the neural lineage.
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